SEP 8, 2026 · PHASE 1 TRIAL
To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
ClinicalTrials.gov
This is a Phase 1 safety and pharmacokinetics study registration with no results posted; it describes planned enrollment and design only, typical of early-stage clinical development.
Reported
Planned enrollment200
Study phasePhase 1
Primary outcome: dose-limiting to…Day 1 up to Day 28 (Day 35 for Arm A)